These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14750937)

  • 21. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
    Schimpf K; Schwarz P; Kunschak M
    Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
    [No Abstract]   [Full Text] [Related]  

  • 22. Advances in the care and treatment of children with hemophilia.
    Manco-Johnson MJ
    Adv Pediatr; 2010; 57(1):287-94. PubMed ID: 21056743
    [No Abstract]   [Full Text] [Related]  

  • 23. Recombinant clotting factors in the treatment of hemophilia.
    Lee C
    Thromb Haemost; 1999 Aug; 82(2):516-24. PubMed ID: 10605745
    [No Abstract]   [Full Text] [Related]  

  • 24. Haemophilia treatment in the United Kingdom from 1969 to 1974.
    Biggs R
    Br J Haematol; 1977 Apr; 35(4):487-504. PubMed ID: 871406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hemophilia].
    Stavem P; Hjort PF
    Tidsskr Nor Laegeforen; 1970 Jul; 90(13):1413-8. PubMed ID: 5453192
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of hemophilia in developing countries.
    Kashyap R; Choudhry VP
    Indian J Pediatr; 2001 Feb; 68(2):151-7. PubMed ID: 11284184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemophilia in childhood.
    McNeill GF; Schwartz E
    Pa Med; 1975 Jan; 78(1):51-3. PubMed ID: 1128902
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence-based use of recombinant FVIIa (NovoSeven, NiaStase) for the treatment of hemophilia with inhibitors in children and adolescents.
    Goldstein B; Geldziler B; Bjerre J; Seremetis S
    Transfus Apher Sci; 2008 Feb; 38(1):25-32. PubMed ID: 18267372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hemophiliacs with inhibitors: cost and effect on blood resources.
    Aledort LM; Cohen M; Hilgartner M; Lipton R
    Prog Clin Biol Res; 1984; 150():353-65. PubMed ID: 6431439
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network.
    Berntorp E; Shapiro AD; Waters J; Astermark J
    Haemophilia; 2014 Sep; 20(5):e362-4. PubMed ID: 25156443
    [No Abstract]   [Full Text] [Related]  

  • 31. Home treatment of haemophilia and Christmas disease: five years' experience.
    Rizza CR; Spooner RJ
    Br J Haematol; 1977 Sep; 37(1):53-66. PubMed ID: 588479
    [No Abstract]   [Full Text] [Related]  

  • 32. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
    Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
    Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).
    Hay CR; Baglin TP; Collins PW; Hill FG; Keeling DM
    Br J Haematol; 2000 Oct; 111(1):78-90. PubMed ID: 11091185
    [No Abstract]   [Full Text] [Related]  

  • 34. [Risk of the appearance of inhibitors linked to the administration of factors VIII and IX. Review of the literature].
    Calvez T; Costagliola D
    Transfus Clin Biol; 1994; 1(6):427-35. PubMed ID: 7881588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substitution treatment of hemophilia a and b.
    Duckert F
    Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemophilia-associated AIDS in the United States, 1981 to September 1987.
    Stehr-Green JK; Holman RC; Jason JM; Evatt BL
    Am J Public Health; 1988 Apr; 78(4):439-42. PubMed ID: 3126675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The current approach to hemophilia.
    Morrison CJ
    J Maine Med Assoc; 1974 Sep; 65(9):205-6. PubMed ID: 4416140
    [No Abstract]   [Full Text] [Related]  

  • 38. Specific therapy in hemophilia.
    Hutaff LW
    N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
    [No Abstract]   [Full Text] [Related]  

  • 39. [Substitution treatment in hemophilia. Critical measures and complications].
    Schimpf K
    Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
    [No Abstract]   [Full Text] [Related]  

  • 40. Options for treating acute bleeds in addition to bypassing agents: extracorporeal immunoadsorption, FVIII/FIX, desmopressin and antifibrinolytics.
    Berntorp E
    Haemophilia; 2006 Dec; 12 Suppl 6():62-5; discussion 65-6. PubMed ID: 17123396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.